{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T16:53:53Z","timestamp":1772988833024,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"vor","delay-in-days":4417,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1111\/j.1538-7836.2010.04020.x","type":"journal-article","created":{"date-parts":[[2010,8,12]],"date-time":"2010-08-12T20:10:26Z","timestamp":1281643826000},"page":"2369-2376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Thromboxane Antagonism with terutroban in Peripheral Arterial Disease: the TAIPAD study"],"prefix":"10.1016","volume":"8","author":[{"given":"J.N.","family":"FIESSINGER","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"BOUNAMEAUX","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"CAIROLS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.L.","family":"CLEMENT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"COCCHERI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.P.","family":"FLETCHER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"HOFFMANN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.G.G.","family":"TURPIE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2010.04020.x_bb0010","first-page":"867","article-title":"Terutroban sodium. prostanoid TP receptor antagonist,antithrombotic agent,antiatherosclerotic agent","volume":"31","author":"Sorbera","year":"2006","journal-title":"Drugs Future"},{"key":"10.1111\/j.1538-7836.2010.04020.x_bb0015","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/01.fjc.0000248234.08277.7e","article-title":"Preclinical evaluation of S18886 in an experimental model of coronary arterial thrombosis","volume":"48","author":"Hong","year":"2006","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1111\/j.1538-7836.2010.04020.x_bb0020","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1160\/TH07-04-0272","article-title":"A thromboxane A2\/prostaglandin H2 receptor antagonist (S18886) shows high antithrombotic efficacy in an experimental model of stent\u2010induced thrombosis","volume":"98","author":"Vilahur","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2010.04020.x_bb0025","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1538-7933.2004.00639.x","article-title":"Antithrombotic effects of S18886,a novel orally active thromboxane A2 receptor antagonist","volume":"2","author":"Osende","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2010.04020.x_bb0030","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1159\/000236915","article-title":"Effect of the thromboxane prostaglandin receptor antagonist terutroban on arterial thrombogenesis after repeated administration in patients treated for the prevention of ischaemic stroke","volume":"28","author":"Bal dit Sollier","year":"2009","journal-title":"Cerebrovasc Dis"},{"key":"10.1111\/j.1538-7836.2010.04020.x_bb0035","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1111\/j.1538-7836.2005.01468.x","article-title":"The specific thromboxane receptor antagonist S18886: pharmacokinetic and pharmacodynamic studies","volume":"3","author":"Gaussem","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2010.04020.x_bb0040","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1177\/000331979905000407","article-title":"Calf pain in middle\u2010aged individuals as a predictor of ischaemic cerebrovascular disease","volume":"50","author":"Elneihoum","year":"1999","journal-title":"Angiology"},{"key":"10.1111\/j.1538-7836.2010.04020.x_bb0045","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0021-9150(97)06089-9","article-title":"Associations of ankle\u2010brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"131","author":"Zheng","year":"1997","journal-title":"Atherosclerosis"},{"key":"10.1111\/j.1538-7836.2010.04020.x_bb0050","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1159\/000212671","volume":"27","author":"Bousser","year":"2009","journal-title":"Cerebrovasc Dis"},{"key":"10.1111\/j.1538-7836.2010.04020.x_bb0055","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1159\/000216835","article-title":"The Prevention of cerebrovascular and cardiovascular Events of ischaemic origin with teRutroban in patients with a history oF ischaemic strOke or tRansient ischaemic attack (PERFORM) study: baseline characteristics of the population","volume":"27","author":"Bousser","year":"2009","journal-title":"Cerebrovasc Dis"},{"key":"10.1111\/j.1538-7836.2010.04020.x_bb0060","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S0140-6736(01)06351-6","article-title":"Peripheral arterial disease","volume":"358","author":"Ouriel","year":"2001","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2010.04020.x_bb0065","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel vs. aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2010.04020.x_bb0070","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta\u2010analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1111\/j.1538-7836.2010.04020.x_bb0075","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1161\/CIRCULATIONAHA.106.174526","volume":"113","author":"Hirsch","year":"2006","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2010.04020.x_bb0080","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1160\/TH09-09-0635","article-title":"Comparaison of efficacy of antiplatelet treatments for patients with claudication A meta\u2010analysis","volume":"103","author":"Basili","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2010.04020.x_bb0085","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1001\/jama.2009.623","article-title":"Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease","volume":"301","author":"Berger","year":"2009","journal-title":"JAMA"},{"key":"10.1111\/j.1538-7836.2010.04020.x_bb0090","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(84)92328-6","article-title":"BM 13.177, a selective blocker of platelet and vessel wall thromboxane receptors, is active in man","volume":"1","author":"Gresele","year":"1984","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2010.04020.x_bb0095","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1211\/0022357991772998","article-title":"Thromboxane A2 receptor antagonism in man and rat by a sulphonylcyanoguanidine (BM\u2010144) and a suphonyurea (BM\u2010500)","volume":"51","author":"Masereel","year":"1999","journal-title":"J Pharm Pharmacol"},{"key":"10.1111\/j.1538-7836.2010.04020.x_bb0100","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1146\/annurev.pharmtox.41.1.661","article-title":"Prostanoid receptors: subtypes and signaling","volume":"41","author":"Breyer","year":"2001","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1111\/j.1538-7836.2010.04020.x_bb0105","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/01.ATV.20.7.1724","article-title":"The thromboxane receptor antagonist S18886 but not aspirin inhibits atherogenesis in apo E\u2010deficient mice: evidence that eicosanoids other than thromboxane contribute to atherosclerosis","volume":"20","author":"Cayatte","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1538-7836.2010.04020.x_bb0110","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1161\/01.CIR.0000015422.86569.52","article-title":"Why are some individuals resistant to the cardioprotective effects of aspirin? Could it be thromboxane A(2)?","volume":"105","author":"Halushka","year":"2002","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2010.04020.x_bb0115","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1161\/01.ATV.20.7.1695","article-title":"TP or not TP: primary mediators in a close runoff?","volume":"20","author":"Pratico","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1538-7836.2010.04020.x_bb0120","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S0735-1097(03)00048-2","article-title":"Improved endothelial function by the thromboxane A2 receptor antagonist S18886 in patients with coronary artery disease treated with aspirin","volume":"41","author":"Belhassen","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1538-7836.2010.04020.x_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2007-1002658","article-title":"A critical reappraisal of the bleeding time","volume":"16","author":"Channing","year":"1990","journal-title":"Semin Thromb Hemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2010.04020.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622066752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622066752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2010.04020.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:50:38Z","timestamp":1761533438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622066752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S1538783622066752"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2010.04020.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thromboxane Antagonism with terutroban in Peripheral Arterial Disease: the TAIPAD study","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2010.04020.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}